Search Results - "Boeckx, Carolien"
-
1
Anti‐Epidermal Growth Factor Receptor Therapy in Head and Neck Squamous Cell Carcinoma: Focus on Potential Molecular Mechanisms of Drug Resistance
Published in The oncologist (Dayton, Ohio) (01-07-2013)“…Targeted therapy against the epidermal growth factor receptor (EGFR) is one of the most promising molecular therapeutics for head and neck squamous cell…”
Get full text
Journal Article -
2
Optimal Evaluation of Programmed Death Ligand-1 on Tumor Cells Versus Immune Cells Requires Different Detection Methods
Published in Archives of pathology & laboratory medicine (1976) (01-08-2018)“…- The benefit of programmed death ligand-1 (PD-L1) immunohistochemistry (IHC) as a method to select patients who may benefit from programmed death receptor-1…”
Get full text
Journal Article -
3
Overcoming cetuximab resistance in HNSCC: The role of AURKB and DUSP proteins
Published in Cancer letters (28-11-2014)“…Highlights • Gene expression profiles of cetuximab sensitive and resistant cells were compared. • Cetuximab resistant cells still exhibit RAS–MAPK signaling…”
Get full text
Journal Article -
4
The intriguing interplay between therapies targeting the epidermal growth factor receptor, the hypoxic microenvironment and hypoxia-inducible factors
Published in Current pharmaceutical design (01-02-2013)“…Despite their individual key roles in promoting cancer progression and treatment resistance, our knowledge about the impact of tumor hypoxia on the activity of…”
Get more information
Journal Article -
5
The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines
Published in BMC research notes (02-06-2015)“…Increased expression of the epidermal growth factor receptor (EGFR) is observed in more than 90% of all head and neck squamous cell carcinomas (HNSCC)…”
Get full text
Journal Article -
6
Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response
Published in BMC research notes (04-06-2014)“…Targeted therapy against the Epidermal Growth Factor Receptor (EGFR) is among the most promising molecular therapeutics for Head and Neck Squamous Cell…”
Get full text
Journal Article -
7
Validated programmed cell death ligand 1 immunohistochemistry assays (E1L3N and SP142) reveal similar immune cell staining patterns in melanoma when using the same sensitive detection system
Published in Histopathology (01-01-2017)“…Aims Tumour cell and/or immune cell programmed cell death ligand 1 (PD‐L1) expression is considered as a potential biomarker for anti‐PD1 and anti‐PD‐L1…”
Get full text
Journal Article -
8
Expression analysis on archival material revisited: isolation and quantification of RNA extracted from FFPE samples
Published in Diagnostic molecular pathology (01-03-2013)“…Formalin-fixed paraffin-embedded (FFPE) tissue is the most readily available source of RNA for the gene expression studies. The main disadvantage is the poor…”
Get more information
Journal Article -
9
Abstract 1030: The intriguing interplay between EGFR inhibitors and the hypoxic microenvironment: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines
Published in Cancer research (Chicago, Ill.) (15-04-2013)“…Abstract Introduction: Since the epidermal growth factor receptor (EGFR) is overexpressed in more than 90% of all head and neck squamous cell carcinomas…”
Get full text
Journal Article -
10
Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factor
Published in American journal of cancer research (01-01-2015)“…After an initial response to EGFR targeted therapy, secondary resistance almost invariably ensues, thereby limiting the clinical benefit of the drug. Hence, it…”
Get full text
Journal Article -
11
Abstract 1898: Potential molecular mechanisms of intrinsic resistance to EGFR-targeting monoclonal antibodies in HNSCC
Published in Cancer research (Chicago, Ill.) (15-04-2012)“…Abstract Background: Head and Neck Squamous Cell Carcinoma (HNSCC) comprises 90% of all head and neck cancers and is still a major cause of morbidity and…”
Get full text
Journal Article -
12
Abstract 5628: Overcoming cetuximab resistance in HNSCC: the role of AURKB and DUSP6
Published in Cancer research (Chicago, Ill.) (15-04-2013)“…Abstract Introduction: As the epidermal growth factor receptor (EGFR) is expressed in up to 90% of all HNSCC tumors and initiates important signaling pathways…”
Get full text
Journal Article -
13
Abstract 280: RNA isolation from formalin-fixed paraffin-embedded material: A comparison of five commercially available RNA isolation kits
Published in Cancer research (Chicago, Ill.) (15-04-2011)“…Abstract Formalin-fixed paraffin-embedded (FFPE) tissue is the most common tissue specimen widely available. Moreover, long clinical follow-up is on hand…”
Get full text
Journal Article -
14
Abstract 2122: KRAS mutation detection using high resolution melting analysis and its prognostic value in archival colorectal cancer tissues
Published in Cancer research (Chicago, Ill.) (15-04-2010)“…Abstract Introduction: The development of targeted therapies has created a pressing clinical need for the rapid and robust molecular characterization of…”
Get full text
Journal Article -
15
Expression analysis on archival material: comparison of 5 commercially available RNA isolation kits for FFPE material
Published in Diagnostic molecular pathology (01-12-2011)“…Formalin-fixed paraffin-embedded (FFPE) tissue is the most common tissue specimen widely available. Moreover, long clinical follow-up is on hand. Therefore,…”
Get more information
Journal Article